Aqueous synthesis of PEGylated Ag 2 S quantum dots and their in vivo tumor targeting behavior

With significantly decreased light scattering and tissue autofluorescence, fluorescence imaging in the second near infrared (NIR-II, 1000-1700 nm) region has been heavily explored in biomedical field recently. Silver sulfide quantum dots (Ag S QDs) with unique optical properties were one of the most...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 2020-09, Vol.529 (4), p.930
Hauptverfasser: Lu, Feng, Ju, Wenwen, Zhao, Ning, Zhao, Ting, Zhan, Chen, Wang, Qi, Fan, Quli, Huang, Wei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:With significantly decreased light scattering and tissue autofluorescence, fluorescence imaging in the second near infrared (NIR-II, 1000-1700 nm) region has been heavily explored in biomedical field recently. Silver sulfide quantum dots (Ag S QDs) with unique optical properties were one of the most classic NIR-II imaging probes. However, the Ag S QDs for in vivo purpose were mainly obtain by oil phase-based high-temperature route at present. Here, we proposed a mild aqueous route to prepare NIR-II emissive Ag S QDs for in vivo tumor imaging. Original Ag S QDs was obtained by mixing sodium sulfide and silver nitrate in a thiol-terminated polyethylene glycol (mPEG-SH) solution. Treating the original Ag S QDs with extra mPEG-SH ligands produced highly PEGyalted Ag S QDs. These re-PEGylated Ag S QDs exhibited much better blood circulation and tumor accumulation in vivo comparing with the original ones, which can serve as excellent tumor imaging probes. The whole-body blood vessel imaging of living mice was achieved with high resolution, the bio-distribution of these QDs were studied by NIR-II imaging as well. This work also highlighted the importance of ligand density for tumor targeting.
ISSN:1090-2104